Neuroprotective effect of etomidate on functional recovery in experimental spinal cord injury

International Journal of Developmental Neuroscience

Volumn 24, Issue 4, 2006, Pages 233-239

  Cayli, Suleyman R ^a   Ates, Ozkan ^a   Karadag, Nese ^a   Altinoz, Eyup ^a   Yucel, Neslihan ^a   Yologlu, Saim ^a   Kocak, Ayhan ^a   Cakir, Celal Ozbek ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Etomidate; Functional recovery; Glutathione; Malondialdehyde; Methylprednisolone; Nitric oxide; Spinal cord injury; Xanthine oxidase

Indexed keywords

ETOMIDATE; GLUTATHIONE; MALONALDEHYDE; METHYLPREDNISOLONE; NITRIC OXIDE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BIOCHEMISTRY; COGNITION; CONTROLLED STUDY; CONVALESCENCE; FEMALE; HISTOPATHOLOGY; LAMINECTOMY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM; SPINAL CORD INJURY;

ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; ETOMIDATE; FEMALE; GLUTATHIONE; LAMINECTOMY; MALONDIALDEHYDE; METHYLPREDNISOLONE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; RANDOM ALLOCATION; RATS; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; STATISTICS, NONPARAMETRIC; XANTHINE OXIDASE;

EID: 33646828525     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2006.04.003     Document Type: Article

References (49)

1. Allen A.R. Surgery of experimental lesion of spinal cord equivalent to crush injury of fracture dislocation of spinal column. A preliminary report. JAMA 57 (1911) 878-880
2. Anderson D.K., Demediuk P., Saunders R.D., Dugan L.L., Means E.D., and Horrocks L.A. Spinal cord injury and protection. Ann. Emerg. Med. 14 (1985) 816-821
3. Anderson D.K., Saunders R.S., Demediuk P., Dugan L.L., Braughler J.M., Hall E.D., Means E.D., and Horrocks L.A. Lipid hydrolysis and peroxidation in injured spinal cord: partial protection with methylprednisolone or Vitamin E and selenium. Cent. Nerv. Syst. Trauma 2 (1985) 257-267
4. Anderson D.K., and Hall E.D. Pathophysiology of spinal cord trauma. Ann. Emerg. Med. 22 (1993) 987-992
5. Anderson D.K., Dugan L.L., Means E.D., and Horrocks L.A. Methylprednisolone and membrane properties of primary cultures of mouse spinal cord. Brain Res. 637 (1994) 119-125
6. Arendt J. Melatonin. Clin. Endocrinol. 29 (1988) 205-229
7. Barut S., Canbolat A., Bilge T., Aydin Y., Cokneseli B., and Kaya U. Lipid peroxidation in experimental spinal cord injury: time-level relationship. Neurosurg. Rev. 16 (1993) 53-59
8. Batjer H.H. Cerebral protective effects of etomidate: experimental and clinical aspects. Cerebrovasc. Brain Metab. Rev. 5 (1993) 17-32
9. Bergen J.M., and Smith D.C. A review of etomidate for rapid sequence intubation in the emergency department. J. Emerg. Med. 15 (1987) 221-230
10. Black P., Markowitz R.S., and Keller S. Naloxane and experimental cord injury. Part 2. Megadose treatment in a dynamic load injury model. Neurosurgery 19 (1986) 909-913
11. Bracken M.B., Shepard M.J., Collins W.F., Holford T.R., Young W., Baskin D.S., Eisenberg H.M., Flamm E., Leo-Summers L., and Maroon J. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Result of the Second National Acute Spinal Cord Injury Study. N. Engl. J. Med. 322 (1990) 1405-1411
12. Braughler J.M., and Hall E.D. Correlation of methylprednisolone levels in cat spinal cord withits effects on (Na + K)-ATP-ase, lipid peroxidation, and alpha motor neuron function. J. Neurosurg. 56 (1982) 838-844
13. Braughler J.M., and Hall E.D. Effects of multi-dose methylprednisolone sodium succinate administration on injured cat spinal cord neurofilament degradation and energy metabolism. J. Neurosurg. 61 (1984) 290-295
14. Braughler J.M., and Hall E.D. Current application of "high dose" steroid therapy for CNS injury. A pharmacological perspective. J. Neurosurg. 62 (1985) 806-810
15. Cayli S.R., Kocak A., Yilmaz U., Tekiner A., Erbil M., Ozturk C., Batcioglu K., and Yologlu S. Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury. Eur. Spine J. 13 (2004) 724-732
16. Corte E.D., and Stirpe F. The regulation of rat liver xanthine oxidase. Involvement of thiol groups in the conversion of the enzyme activity from dehydrogenase (type D) into oxidase (type O) and purification of the enzyme. Biochem. J. 126 (1972) 739-745
17. Demediuk P., Saunders R.D., Clendenon N.R., Means E.D., Anderson D.K., and Horrocks L.A. Changes in lipid metabolism in traumatized spinal cord. Prog. Brain Res. 63 (1985) 1-16
18. Dixon C.E., Ma X., Kline A.E., Yan H.Q., Ferimer H., Kochanek P.M., Wisniewski S.R., Jenkins L.W., and Marion D.W. Acute etomidate treatment reduces cognitive deficits and histopathology in rats with traumatic brain injury. Crit. Care Med. 31 (2003) 2222-2227
19. Ducker T.B., Kindt G.W., and Kempe L.G. Pathological findings in acute experimental spinal cord trauma. J. Neurosurg. 35 (1971) 700-708
20. Elman G.L. Tissue sulphydryl groups. Arch. Biochem. Biophys. 82 (1959) 70-77
21. Evans R.H., and Hill R.G. GABA-mimetic action of etomidate. Experientia 34 (1978) 1325-1327
22. Farooque M., Isaksson J., Jackson D., and Olsson Y. Clomethiazole improves hind limb function and reduces neuronal damage after severe spinal cord injury in rat. Acta Neuropathol. 98 (1999) 22-30
23. Fercakova A., Halat G., Marsala M., Lukacova N., and Marsala J. Graded postischemic reoxigenation reduces lipid peroxidation and reperfusion injury in the rabbit spinal cord. Brain Res. 593 (1992) 159-167
24. Frizell R.T., Meyer Y.J., Borchers D.J., Weprin B.E., Allen E.C., Pogue W.R., Reisch J.S., Cherrington A.D., and Batjer H.H. The effects of etomidate on cerebral metabolism and blood flow in a canine model for hypoperfusion. J. Neurosurg. 74 (1991) 263-269
25. Gale K., Kerasidis H., and Wrathall J.R. Spinal cord contusions in the rat: behavioral analysis of functional neurologic impairment. Exp. Neurol. 88 (1985) 123-134
26. Goldberger M.E., Bregman B.S., Vierck Jr. C.J., and Brown M. Criteria for assesing recovery of function after spinal cord injury: behavioral methods. Exp. Neurol. 107 (1990) 113-117
27. Guo J., White J.A., and Batjer H.H. Limited protective effects of etomidate during brainstem ischemia in dogs. J. Neurosurg. 82 (1995) 278-283
28. Hall E.D. The neuroprotective pharmacology of methylprednisolone. J. Neurosurg. 76 (1992) 13-22
29. Hall E.D. Lipid peroxidants in acute central nervous system injury. Ann. Emerg. Med. 22 (1993) 1022-1027
30. Hille R., and Nishino T. Flavoprotein structure and mechanism. 4. Xanthine oxidase and xanthine dehydrogenase. FASEB J. 9 (1995) 995-1003
31. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., and Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 9265-9269
32. Levy M.L., Aranda M., Zelman V., and Giannotta S.L. Propylene glycol toxicity following continuous etomidate infusion for the control of refractory cerebral edema. Neurosurgery 37 (1995) 363-371
33. Mihara S., and Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 86 (1978) 271-278
34. Moncada S., and Higgs A. The l-arginine-nitric oxide pathway. N. Engl. J. Med. 329 (1993) 2002-2012
35. 3H]GABA release from cat cortical synaptosomes. Anesthesiology 89 (1998) 919-928
36. Ozbek E., Turkoz Y., Gokdeniz R., Davarci M., and Ozugurlu F. Increased nitric oxide production in the spermatic vein of patients with varicocele. Eur. Urol. 37 2 (2000) 172-175
37. Patel P.M., Goskowicz R.L., Drummond J.C., and Cole D.J. Etomidate reduces ischemia induced glutamate release in the hippocampus in rats subjected to incomplete forebrain ischemia. Anesth. Analg. 80 (1995) 933-939
38. Peunova N., and Enikolopov G. Amplification of calcium-induced gene transcription by nitric oxide in neuronal cells. Nature 364 (1993) 450-453
39. Prajda N., and Weber G. Malignant transformation-linked imbalance: decreased xanthine oxidase activity in hepatomas. FEBS Lett. 59 (1975) 245-249
40. Prior J.G.L., Hinds C.J., Williams J., and Prior P.F. The use of etomidate in the management of severe head injury. Intens. Care Med. 9 (1983) 313-320
41. Rawe S.E., Lee W.A., and Perot P.L. Spinal cord glucose utilization after experimental spinal cord injury. Neurosurgery 9 (1981) 40-47
42. Rivlin A.S., and Tator C.H. Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J. Neurosurg. 47 (1977) 577-581
43. Saruhashi Y., Matsusue Y., and Hukuda S. Effects of seratonin 1A agonist on acute spinal cord injury. Spinal Cord 40 (2002) 519-523
44. Saunders R.D., Dugan L.L., Demediuk P., Means E.D., Horrocks L.A., and Anderson D.K. Effects of methylprednisolone and the combination of alpha-tocopherol and selenium on arachidonic acid metabolism and lipid peroxidation in traumatized spinal cord tissue. J. Neurochem. 49 (1987) 24-31
45. Tator C.H., and Fehlings M.G. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J. Neurosurg. 75 (1991) 15-26
46. Von Euler M., Akesson E., Samuelsson E.B., Seiger A., and Sundström E. Motor performance score: a new algorithm for accurate behavioral testing of spinal cord injury in rats. Exp. Neurol. 137 (1996) 242-245
47. Watson, J.C., Drummond, J.C., Patel, P.M., Sano, T., Akrawi, W., U, H.S., 1992. An assessment of the cerebral protective effects of etomidate in a model of incomplete forebrain ischemia in the rat. Neurosurgery 30, 540-544.
48. Young W., and Flamm E.S. Effects of high-dose corticosteroid therapy on blood flow, evoked potentials and extracellular calcium in experimental spinal cord injury. J. Neurosurg. 57 (1982) 667-673
49. Young W. Medical treatments of acute spinal cord injury. J. Neurol. Neurosurg. Psychiatry 55 (1992) 635-639